Personal information

Other IDs

Loop profile: 1345774

Activities

Collapse all

Employment (1)

CHDI Management/CHDI Foundation: New York, NY, US

Employment
Source: Self-asserted source
Emily Gantman

Education and qualifications (1)

The Rockefeller University: New York, NY, US

PhD
Education
Source: Self-asserted source
Emily Gantman

Works (14)

Time to Functional Loss as an Endpoint in Huntington's Disease Trials: Enrichment and Sample Size

Movement Disorders
2024-10 | Journal article
DOI: 10.1002/mds.29963
Contributors: James A. Mills; Jeffrey D. Long; Jatin G. Vaidya; Emily C. Gantman; Swati Sathe; Sarah J. Tabrizi; Cristina Sampaio
Source: check_circle
Crossref

Towards Standardizing Nomenclature in Huntington's Disease Research.

Journal of Huntington's disease
2024-07-02 | Journal article
DOI: 10.3233/jhd-240044
PMID: 38968054
Contributors: DiFiglia M; Leavitt BR; Macdonald D; Thompson LM; Huntington’s Disease Nomenclature Working Group:
Source: Self-asserted source
Emily Gantman

Applying the Huntington's Disease Integrated Staging System (HD-ISS) to Observational Studies.

Journal of Huntington's disease
2023-05-02 | Journal article
DOI: 10.3233/jhd-220555
PMID: 37092230
Contributors: Jeffrey Long; Gantman EC; Mills JA; Vaidya JG; Mansbach A; Sarah Tabrizi; Sampaio C
Source: Self-asserted source
Emily Gantman

A biological classification of Huntington's disease: the Integrated Staging System.

The Lancet. Neurology
2022-07-01 | Journal article
DOI: 10.1016/s1474-4422(22)00120-x
PMID: 35716693
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Huntington's Disease Regulatory Science Consortium: Accelerating Medical Product Development.

Journal of Huntington's disease
2022-01-01 | Journal article
DOI: 10.3233/jhd-220533
PMID: 35466945
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Recommendations to Optimize the Use of Volumetric MRI in Huntington's Disease Clinical Trials.

Frontiers in neurology
2021-10-22 | Journal article
DOI: 10.3389/fneur.2021.712565
PMID: 34744964
PMC: PMC8569234
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Volumetric MRI-Based Biomarkers in Huntington's Disease: An Evidentiary Review.

Frontiers in neurology
2021-09-21 | Journal article
DOI: 10.3389/fneur.2021.712555
PMID: 34621236
PMC: PMC8490802
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Huntington’s Disease Integrated Staging System (HD-ISS): A Novel Evidence-Based Classification System For Staging

2021-09-11 | Other
DOI: 10.1101/2021.09.01.21262503
Contributors: Sarah J. Tabrizi; Scott Schobel; Emily C. Gantman; Alexandra Mansbach; Beth Borowsky; Pavlina Konstantinova; Tiago A. Mestre; Jennifer Panagoulias; Christopher A. Ross; Maurice Zauderer et al.
Source: check_circle
Crossref

Epitranscriptomic profiling across cell types reveals associations between APOBEC1-mediated RNA editing, gene expression outcomes, and cellular function.

Proceedings of the National Academy of Sciences of the United States of America
2017-11-22 | Journal article
DOI: 10.1073/pnas.1714227114
PMID: 29167373
PMC: PMC5740640
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

T cells presenting viral antigens or autoantigens induce cytotoxic T cell anergy.

JCI insight
2017-11-02 | Journal article
DOI: 10.1172/jci.insight.96173
PMID: 29093272
PMC: PMC5752293
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

A majority of m6A residues are in the last exons, allowing the potential for 3' UTR regulation.

Genes & development
2015-09-24 | Journal article
DOI: 10.1101/gad.269415.115
PMID: 26404942
PMC: PMC4604345
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

T cells targeting a neuronal paraneoplastic antigen mediate tumor rejection and trigger CNS autoimmunity with humoral activation.

European journal of immunology
2014-11-01 | Journal article
DOI: 10.1002/eji.201444624
PMID: 25103845
PMC: PMC4296561
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Mapping Argonaute and conventional RNA-binding protein interactions with RNA at single-nucleotide resolution using HITS-CLIP and CIMS analysis.

Nature protocols
2014-01-09 | Journal article
DOI: 10.1038/nprot.2014.012
PMID: 24407355
PMC: PMC4156013
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman

Loss of TGFbeta signaling destabilizes homeostasis and promotes squamous cell carcinomas in stratified epithelia.

Cancer cell
2007-10-01 | Journal article
DOI: 10.1016/j.ccr.2007.08.020
PMID: 17936557
PMC: PMC2424201
Contributors: Emily Gantman
Source: Self-asserted source
Emily Gantman
How many people are using ORCID?